Interferon γ-induced intratumoral expression of CXCL9 alters the local distribution of T cells following immunotherapy with Listeria monocytogenes

References

• Hussain SF, Paterson Y. What is needed for effective antitumor immunotherapy? Lessons learned using Listeria monocytogenes as a live vector for HPV-associated tumors. [doi] Cancer Immunol Immunother 2005; 54:577 - 86; http://dx.doi.org/10.1007/s00262-004-0600-2; PMID: 15650885
   PubMed Web of Science ®Google Scholar
• Peng X, Hussain SF, Paterson Y. The ability of two Listeria monocytogenes vaccines targeting human papillomavirus-16 E7 to induce an antitumor response correlates with myeloid dendritic cell function. J Immunol 2004; 172:6030 - 8; PMID: 15128786
   PubMed Web of Science ®Google Scholar
• Dominiecki ME, Beatty GL, Pan ZK, Neeson P, Paterson Y. Tumor sensitivity to IFN-gamma is required for successful antigen-specific immunotherapy of a transplantable mouse tumor model for HPV-transformed tumors. [doi] Cancer Immunol Immunother 2005; 54:477 - 88; http://dx.doi.org/10.1007/s00262-004-0610-0; PMID: 15750832
   PubMed Web of Science ®Google Scholar
• Gunn GR, Zubair A, Peters C, Pan ZK, Wu TC, Paterson Y. Two Listeria monocytogenes vaccine vectors that express different molecular forms of human papilloma virus-16 (HPV-16) E7 induce qualitatively different T cell immunity that correlates with their ability to induce regression of established tumors immortalized by HPV-16. J Immunol 2001; 167:6471 - 9; PMID: 11714814
   PubMed Web of Science ®Google Scholar
• Groom JR, Luster AD. CXCR3 in T cell function. Exp Cell Res 2011; 317:620 - 31; http://dx.doi.org/10.1016/j.yexcr.2010.12.017; PMID: 21376175
   PubMed Web of Science ®Google Scholar
• Sgadari C, Angiolillo AL, Cherney BW, Pike SE, Farber JM, Koniaris LG, et al. Interferon-inducible protein-10 identified as a mediator of tumor necrosis in vivo. Proc Natl Acad Sci USA 1996; 93:13791 - 6; http://dx.doi.org/10.1073/pnas.93.24.13791; PMID: 8943014
   PubMed Web of Science ®Google Scholar
• Sgadari C, Farber JM, Angiolillo AL, Liao F, Teruya-Feldstein J, Burd PR, et al. Mig, the monokine induced by interferon-gamma, promotes tumor necrosis in vivo. Blood 1997; 89:2635 - 43; PMID: 9108380
   PubMed Web of Science ®Google Scholar
• Gorbachev AV, Kobayashi H, Kudo D, Tannenbaum CS, Finke JH, Shu S, et al. CXC chemokine ligand 9/monokine induced by IFN-gamma production by tumor cells is critical for T cell-mediated suppression of cutaneous tumors. J Immunol 2007; 178:2278 - 86; PMID: 17277133
   PubMed Web of Science ®Google Scholar
• Ruehlmann JM, Xiang R, Niethammer AG, Ba Y, Pertl U, Dolman CS, et al. MIG (CXCL9) chemokine gene therapy combines with antibody-cytokine fusion protein to suppress growth and dissemination of murine colon carcinoma. Cancer Res 2001; 61:8498 - 503; PMID: 11731434
   PubMed Web of Science ®Google Scholar
• Tannenbaum CS, Tubbs R, Armstrong D, Finke JH, Bukowski RM, Hamilton TA. The CXC chemokines IP-10 and Mig are necessary for IL-12-mediated regression of the mouse RENCA tumor. J Immunol 1998; 161:927 - 32; PMID: 9670971
   PubMed Web of Science ®Google Scholar
• Dorsey R, Kundu N, Yang Q, Tannenbaum CS, Sun H, Hamilton TA, et al. Immunotherapy with interleukin-10 depends on the CXC chemokines inducible protein-10 and monokine induced by IFN-gamma. Cancer Res 2002; 62:2606 - 10; PMID: 11980656
   PubMed Web of Science ®Google Scholar
• Narvaiza I, Mazzolini G, Barajas M, Duarte M, Zaratiegui M, Qian C, et al. Intratumoral coinjection of two adenoviruses, one encoding the chemokine IFN-gamma-inducible protein-10 and another encoding IL-12, results in marked antitumoral synergy. J Immunol 2000; 164:3112 - 22; PMID: 10706701
   PubMed Web of Science ®Google Scholar
• Pertl U, Luster AD, Varki NM, Homann D, Gaedicke G, Reisfeld RA, et al. IFN-gamma-inducible protein-10 is essential for the generation of a protective tumor-specific CD8 T cell response induced by single-chain IL-12 gene therapy. J Immunol 2001; 166:6944 - 51; PMID: 11359856
   PubMed Web of Science ®Google Scholar
• Groom JR, Luster AD. CXCR3 ligands: redundant, collaborative and antagonistic functions. Immunol Cell Biol 2011; 89:207 - 15; http://dx.doi.org/10.1038/icb.2010.158; PMID: 21221121
   PubMed Web of Science ®Google Scholar
• Muthuswamy R, Berk E, Junecko BF, Zeh HJ, Zureikat AH, Normolle D, et al. NF-κB hyperactivation in tumor tissues allows tumor-selective reprogramming of the chemokine microenvironment to enhance the recruitment of cytolytic T effector cells. Cancer Res 2012;; 72:3735 - 43; http://dx.doi.org/10.1158/0008-5472.CAN-11-4136; PMID: 22593190
   PubMed Web of Science ®Google Scholar
• Guirnalda P, Paterson Y. Vaccination with immunotherapeutic Listeria monocytogenes induces IL-17+ γδ T cells in a murine model for HPV associated cancer. OncoImmunology 2012; 1:822 - 828; http://dx.doi.org/10.4161/onci.20491
   PubMed Web of Science ®Google Scholar
• Carr DJ, Wuest T, Ash J. An increase in herpes simplex virus type 1 in the anterior segment of the eye is linked to a deficiency in NK cell infiltration in mice deficient in CXCR3. [doi] J Interferon Cytokine Res 2008; 28:245 - 51; http://dx.doi.org/10.1089/jir.2007.0110; PMID: 18439102
   PubMed Web of Science ®Google Scholar
• Raitano AB, Scuderi P, Korc M. Upregulation of interferon-gamma binding by tumor necrosis factor and lymphotoxin: disparate potencies of the cytokines and modulation of their effects by phorbol ester. J Interferon Res 1991; 11:61 - 7; http://dx.doi.org/10.1089/jir.1991.11.61; PMID: 1903142
   PubMedGoogle Scholar
• Raitano AB, Korc M. Tumor necrosis factor up-regulates gamma-interferon binding in a human carcinoma cell line. J Biol Chem 1990; 265:10466 - 72; PMID: 2141333
   PubMed Web of Science ®Google Scholar
• Kondo T, Nakazawa H, Ito F, Hashimoto Y, Osaka Y, Futatsuyama K, et al. Favorable prognosis of renal cell carcinoma with increased expression of chemokines associated with a Th1-type immune response. Cancer Sci 2006; 97:780 - 6; http://dx.doi.org/10.1111/j.1349-7006.2006.00231.x; PMID: 16863511
   PubMed Web of Science ®Google Scholar
• Harlin H, Meng Y, Peterson AC, Zha Y, Tretiakova M, Slingluff C, et al. Chemokine expression in melanoma metastases associated with CD8+ T-cell recruitment. Cancer Res 2009; 69:3077 - 85; http://dx.doi.org/10.1158/0008-5472.CAN-08-2281; PMID: 19293190
   PubMed Web of Science ®Google Scholar
• Mlecnik B, Tosolini M, Charoentong P, Kirilovsky A, Bindea G, Berger A, et al. Biomolecular network reconstruction identifies T-cell homing factors associated with survival in colorectal cancer. Gastroenterology 2010; 138:1429 - 40; http://dx.doi.org/10.1053/j.gastro.2009.10.057; PMID: 19909745
   PubMed Web of Science ®Google Scholar
• Hong M, Puaux AL, Huang C, Loumagne L, Tow C, Mackay C, Kato M, Prevost-Blondel A, Avril MF, Nardin A, Abastado JP. Chemotherapy induces intratumoral expression of chemokines in cutaneous melanoma, favoring T-cell infiltration and tumor control. Cancer Res:2011; 71:22 6997 - 7009
   Google Scholar
• Huang H, Liu Y, Xiang J. Synergistic effect of adoptive T-cell therapy and intratumoral interferon gamma-inducible protein-10 transgene expression in treatment of established tumors. Cell Immunol 2002; 217:12 - 22; http://dx.doi.org/10.1016/S0008-8749(02)00508-7; PMID: 12425997
   PubMed Web of Science ®Google Scholar
• Maciag PC, Radulovic S, Rothman J. The first clinical use of a live-attenuated Listeria monocytogenes vaccine: a Phase I safety study of Lm-LLO-E7 in patients with advanced carcinoma of the cervix. Vaccine 2009; 27:3975 - 83; http://dx.doi.org/10.1016/j.vaccine.2009.04.041; PMID: 19389451
   PubMed Web of Science ®Google Scholar
• Lin KY, Guarnieri FG, Staveley-O’Carroll KF, Levitsky HI, August JT, Pardoll DM, et al. Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen. Cancer Res 1996; 56:21 - 6; PMID: 8548765
   PubMed Web of Science ®Google Scholar
• Fearon ER, Itaya T, Hunt B, Vogelstein B, Frost P. Induction in a murine tumor of immunogenic tumor variants by transfection with a foreign gene. Cancer Res 1988; 48:2975 - 80; PMID: 3259156
   PubMed Web of Science ®Google Scholar
• Murphy GP, Hrushesky WJ. A murine renal cell carcinoma. J Natl Cancer Inst 1973; 50:1013 - 25; PMID: 4703766
   PubMed Web of Science ®Google Scholar
• Beatty GL, Paterson Y. IFN-gamma can promote tumor evasion of the immune system in vivo by down-regulating cellular levels of an endogenous tumor antigen. J Immunol 2000; 165:5502 - 8; PMID: 11067903
   PubMed Web of Science ®Google Scholar
• Reilly RT, Gottlieb MB, Ercolini AM, Machiels JP, Kane CE, Okoye FI, et al. HER-2/neu is a tumor rejection target in tolerized HER-2/neu transgenic mice. Cancer Res 2000; 60:3569 - 76; PMID: 10910070
   PubMed Web of Science ®Google Scholar
• Aslakson CJ, Miller FR. Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor. Cancer Res 1992; 52:1399 - 405; PMID: 1540948
   PubMed Web of Science ®Google Scholar
• Pulaski BA, Ostrand-Rosenberg S. Mouse 4T1 breast tumor model. Curr Protoc Immunol 2001; Chapter 20:Unit 20 22. http://dx.doi.org/10.1002/0471142735.im2002s39
   Google Scholar
• Kowalczyk DW, Wlazlo AP, Blaszczyk-Thurin M, Xiang ZQ, Giles-Davis W, Ertl HC. A method that allows easy characterization of tumor-infiltrating lymphocytes. J Immunol Methods 2001; 253:163 - 75; http://dx.doi.org/10.1016/S0022-1759(01)00356-8; PMID: 11384678
   PubMed Web of Science ®Google Scholar
• Darnell JC, Albert ML, Darnell RB. Cdr2, a target antigen of naturally occuring human tumor immunity, is widely expressed in gynecological tumors. Cancer Res 2000; 60:2136 - 9; PMID: 10786675
   PubMed Web of Science ®Google Scholar
• Krawczyk CM, Shen H, Pearce EJ. Memory CD4 T cells enhance primary CD8 T-cell responses. Infect Immun 2007; 75:3556 - 60; http://dx.doi.org/10.1128/IAI.00086-07; PMID: 17438031
   PubMed Web of Science ®Google Scholar
• Tindle RW, Fernando GJ, Sterling JC, Frazer IH. A “public” T-helper epitope of the E7 transforming protein of human papillomavirus 16 provides cognate help for several E7 B-cell epitopes from cervical cancer-associated human papillomavirus genotypes. Proc Natl Acad Sci U S A 1991; 88:5887 - 91; http://dx.doi.org/10.1073/pnas.88.13.5887; PMID: 1712110
   PubMed Web of Science ®Google Scholar